Background: Sickle cell anemia (SCA) has been linked with altered plasma levels of D‑dimer. However, routine assessment of D‑dimer and other coagulation indices in SCA patients are rarely carried out. The aim of this study was to determine the mean plasma levels of D‑dimer and other coagulation indices in children with SCA in a steady state and them with with that of healthy HbAA genotype controls. Materials and Methods: This was a case–control study involving 40 children with SCA in steady state and 40 healthy HbAA genotype controls. Plasma D‑dimer, prothrombin time (PT), activated partial thromboplastin time (aPTT), and platelet count were determined using appropriate laboratory techniques. Data analysis was by JMP software. Independent t...
Background: Sickle cell anemia (SCA) is an inherited hemoglobin (Hb) disorder with susceptibility fo...
Objective: This study aims to examine markers of coagulation activation and their possible clinical ...
BackgroundThe contribution of hypercoagulability to the pathophysiology of sickle cell disease (SCD)...
Background: Sickle cell anemia (SCA) has been linked with altered plasma levels of D-dimer. However,...
Background: Sickle cell anemia is associated with a hypercoagulable state that may lead to alteratio...
Background: The pathophysiology of vaso-occlusive crises in sickle cell anaemia (SCA) is multifactor...
Introduction: Sickle cell anaemia (SCA) is an inherited abnormality of haemoglobin associated w...
Objective: Sickle cell disease (SCD) is a hereditary blood disorder characterized by an abnormality ...
Sickle cell disease (SCD) is a group of blood disorders typically inherited from a person's parents....
Background: Sickle cell disease (SCD) is considered to be a hypercoagulable state that contributes t...
Background: Sickle cell anemia (SCA) has multisystemic manifestations and is associated with severe ...
Background: Reports from various studies showed that patients with sickle cell anemia (SCA) have alt...
Background: Alterations in the components of hemostasis, namely platelet function, the procoagulant,...
Background: It has been reported that patients with SCD do have an abnormal coagulation profile. C...
Background: Foetal haemoglobin (HbF) is a major modifying factor influencing sickle cell disease (SC...
Background: Sickle cell anemia (SCA) is an inherited hemoglobin (Hb) disorder with susceptibility fo...
Objective: This study aims to examine markers of coagulation activation and their possible clinical ...
BackgroundThe contribution of hypercoagulability to the pathophysiology of sickle cell disease (SCD)...
Background: Sickle cell anemia (SCA) has been linked with altered plasma levels of D-dimer. However,...
Background: Sickle cell anemia is associated with a hypercoagulable state that may lead to alteratio...
Background: The pathophysiology of vaso-occlusive crises in sickle cell anaemia (SCA) is multifactor...
Introduction: Sickle cell anaemia (SCA) is an inherited abnormality of haemoglobin associated w...
Objective: Sickle cell disease (SCD) is a hereditary blood disorder characterized by an abnormality ...
Sickle cell disease (SCD) is a group of blood disorders typically inherited from a person's parents....
Background: Sickle cell disease (SCD) is considered to be a hypercoagulable state that contributes t...
Background: Sickle cell anemia (SCA) has multisystemic manifestations and is associated with severe ...
Background: Reports from various studies showed that patients with sickle cell anemia (SCA) have alt...
Background: Alterations in the components of hemostasis, namely platelet function, the procoagulant,...
Background: It has been reported that patients with SCD do have an abnormal coagulation profile. C...
Background: Foetal haemoglobin (HbF) is a major modifying factor influencing sickle cell disease (SC...
Background: Sickle cell anemia (SCA) is an inherited hemoglobin (Hb) disorder with susceptibility fo...
Objective: This study aims to examine markers of coagulation activation and their possible clinical ...
BackgroundThe contribution of hypercoagulability to the pathophysiology of sickle cell disease (SCD)...